Herpes simplex virus: Treatment with antimicrobial peptides

Advances in Experimental Medicine and Biology

Volumn 601, Issue , 2007, Pages 369-376

  Kovalchuk, Leonid V ^a   Gankovskaya, Ludmila V ^a   Gankovskaya, Oksana A ^b   Lavrov, Vyacheslav F ^b  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b MECHNIKOV RESEARCH INSTITUTE FOR VACCINES AND SERA   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; ANTIVIRUS AGENT; CYTOKINE; PEPTIDE;

ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DRUG EFFECT; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; REVIEW; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIVIRAL AGENTS; CYTOKINES; HERPES SIMPLEX; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; PEPTIDES; SIMPLEXVIRUS; VIRUS REPLICATION;

EID: 34848853655     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-72005-0_39     Document Type: Conference Paper

References (34)

1. Abrahams, V.M. and Mor, G. (2005) Toll-like receptors and their role in the trophoblast. Placenta 26, 540-547.
2. Andersen, J.M., Al-Khairy, D. and Ingalls, R.R. (2006) Innate immunity at the mucosal surface: Role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol. Reprod. 74, 824-831.
3. Anumba, D.O. (2005) Characterization of toll-like receptors in the female reproductive tract in humans. Hum. Reprod. 20, 1372-1378.
4. Barinskii, I.F., Posevaia, T.A., Shabalina, N.V. and Nikitina A.A. (2005) Herpes virus infec-tion in patients with chronic glomerulonephritis. Vopr. Virusol. (Russ.) 50, 35-37.
5. Boman, H. (2003) Antibacterial peptides: Basic facts and emerging concepts. J. Intern. Med. 254, 197-215.
6. Bowie, A.G. and Haga, I.R. (2005) The role of Toll-like receptors in the host response to viruses. Mol. Immunol. 42, 859-867.
7. Cunningham, A.L., Diefenbach, R.J., Miranda-Saksena, M., Bosnjak, L., Kim, M., Jones, C. and Douglas, M.W. (2006) The cycle of human herpes simplex virus infection: Virus transport and immune control. J. Infect. Dis. 194, 11-18.
8. Duerst, R.J. and Morrison L.A. (2003) Innate immunity to herpes simplex virus type 2. Viral Immunol. 16, 475-490.
9. Ellermann-Eriksen, S. (2005) Macrophages and cytokines in the early defense against herpes simplex virus. Virology J. 2, 1-30.
10. Fahlgren, A., Hammarstrom, S., Danielsson, A. and Hammarstrom, M.L. (2004) Beta- Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin. Exp. Immunol. 137, 379-385.
11. Garner, J.A. (2003) Herpes simplex virion entry into and intracellular transport within mammalian cells. Adv. Drug Deliv. Rev. 55, 1497-1513.
12. Garzino-Demo, A. (2007) Chemokines and defensins as HIV suppressive factors: An evolving story. Curr. Pharm. Des. 13, 163-172.
13. Grunewald, K., Desai, P., Winkler, D.C., Heymann, J.B., Belnap, D.M., Baumeister, W. and Steven, A.C. (2003) Three-dimensional structure of herpes simplex virus from Cryo- electron tomography. Science 302, 1396-1398.
14. Gupta, A.K., Cherman, A.M. and Tyring, S.K. (2004) Viral and nonviral uses of imiquimod: A review. J. Cutan. Med. Surg. 8, 338-352.
15. Harandi, A.M., Eriksson, K. and Holmgren, J. (2003) A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J. Virol. 77, 953-962.
16. Herbst-Kralovetz1, M.M. and Pyles, R.B. (2006) Toll-like receptors, innate immunity and HSV pathogenesis. Herpes 13, 37-41.
17. Hollier, L.M. and Grissom, H. (2005) Human herpes viruses in pregnancy: Cytomegalovirus, Epstein-Barr virus, and varicella zoster virus. Clin. Perinatol. 32, 671-696.
18. Howell, M., Jones, J. and Kisich, K. (2004) Selective killing of vaccinia virus by LL-37: Implications for eczema vaccinatum1. J. Immunol. 172, 1763-1767.
19. Hugseyin Baskin, H., Ellermann-Eriksen, S., Lovmand, J. and Mogensen, S.C. (1997) Herpes simplex virus type 2 synergizes with interferon-c in the induction of nitric oxide production in mouse macrophages through autocrine secretion of tumour necrosis factor-a. J. Gen. Virol. 78, 195-203.
20. Khanna, K.M., Lepisto, A.J., Decman, V. and Hendricks, R.L. (2004) Immune control of herpes simplex virus during latency. Curr. Opin. Immunol. 16, 463-469.
21. Kokriakov, V.N., Koval'chuk, L.V., Aleshina, G.M. and Shamova, O.V. (2006) Cationic antimicrobial peptides as molecular immunity factors: Multi-functionality. Zh. Mikrobiol. Epidemiol. Immunobiol. (Russ.) 2, 98-105.
22. Koval'chuk, L.V., Gankovskaia, L.V., Moroz, A.F., Avedova, T.A. and Ukhina, T.V. (2004) Antistaphylococcal activity of the complex of natural cytokines. Zh. Mikrobiol. Epidemiol. Immunobiol. (Russ.) 1, 55-59.
23. Koval'chuk, L.V., Lavrov, V.F., Gankovskaia, L.V., Ebralidze, L.K. and Barkevich, O.A. (2005) In vitro inhibition of the cytopathic action of herpes simplex virus, type 1, with a natural cytokine complex. Zh. Mikrobiol. Epidemiol. Immunobiol. J 1, 57-60
24. Lehrer, R. and Ganz, T. (2002). Cathelicidins: A family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 9, 18-22.
25. Malmgaard, L. and Paludan, S. (2003) Interferon (IFN)-a/b, interleukin (IL)-12 and IL-18 coordinately induce production of IFN-c during infection with herpes simplex virus type 2. J. Gen. Virol. 84, 2497-2500.
26. Milligan, G.N. (1999) Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. J. Virol. 73, 6380-6386.
27. Ouellette, A.J. and Bevins, C.L. (2001) Paneth cell defensins and innate immunity of the small bowel. Inflamm. Bowel Dis. 7, 43-50.
28. Pyles, R.B., Higgins, D., Chalk, C., Zalar, A., Eiden, J. and Brown, C. (2002) Use of immunostimulatory sequence containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. J. Virol. 76, 11387-11396.
29. Spear, P.G. (2004) Herpes simplex virus entry receptors and viral ligands. Cell. Microbiol. 6, 401-410.
30. Thompson, K.A., Strayer, D.R., Salvato, P.D., Thompson, C.E., Klimas, N. and Molavi, A. (1996) Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection. Eur. J. Clin. Microbiol. Infect. 15, 580-587.
31. Yasin, B., Pang, M. and Turner, J. (2000) Evaluation of inactivation of infectious HSV by host-defense peptides. Eur. J. Clin. Microbiol. Infect. Dis. 19, 187-194.
32. Yasin, B., Wang, W., Pang, M., Cheshenko, N., Hong, T., Waring, A.J., Herold, B.C., Wagar, E.A. and Lehrer R.I. (2004) Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J. Virol. 78, 5147-5156.
33. Zasloff, M. (2002) Antimicrobial peptides of multicellular organism. Nature 415, 389-395.
34. Zughaier, S.M., Shafer, W.M. and Stephens, D.S. (2005) Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell. Microbiol. 7, 1251-1261.